These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 26992727)

  • 61. Large rectovaginal fistula due to a cube pessary despite routine follow-up; but what is 'routine'?
    Torbey MJ
    J Obstet Gynaecol Res; 2014 Nov; 40(11):2162-5. PubMed ID: 25164211
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The history and usage of the vaginal pessary: a review.
    Oliver R; Thakar R; Sultan AH
    Eur J Obstet Gynecol Reprod Biol; 2011 Jun; 156(2):125-30. PubMed ID: 21255901
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Pathophysiology of Vaginal Erosions in Women Using Pessary: A Pilot Study Examining Vaginal Microbiota.
    Bouchard ME; Rousseau E; Fortier LC; Girard I
    J Obstet Gynaecol Can; 2021 Aug; 43(8):943-948. PubMed ID: 33933709
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Pelvic organ prolapse during pregnancy: treatment with vaginal pessary. A report of two cases].
    Arango-Buitrago V; Restrepo-Moreno M; Echavarría-Restrepo LG; Gómez-Londoño M
    Ginecol Obstet Mex; 2016 Sep; 84(9):601-6. PubMed ID: 29424981
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Vaginal pessary treatment in women with symptomatic pelvic organ prolapse: a long-term prospective study.
    Ma C; Zhou Y; Kang J; Zhang Y; Ma Y; Wang Y; Tian W; Xu T; Liang S; Fan G; Cui Y; Zhu L
    Menopause; 2021 Feb; 28(5):538-545. PubMed ID: 33625108
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Induction of labour: a comparison between controlled-release dinoprostone vaginal pessary (Cervidil) and dinoprostone intravaginal gel (Prostin E2).
    Kho EM; Sadler L; McCowan L
    Aust N Z J Obstet Gynaecol; 2008 Oct; 48(5):473-7. PubMed ID: 19032662
    [TBL] [Abstract][Full Text] [Related]  

  • 67. RETIRED: Technical update on pessary use.
    Robert M; Schulz JA; Harvey MA;
    J Obstet Gynaecol Can; 2013 Jul; 35(7):664-674. PubMed ID: 23876646
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Nonsurgical management of a rectovaginal fistula caused by a Gellhorn pessary.
    Cichowski S; Rogers RG
    Obstet Gynecol; 2013 Aug; 122(2 Pt 2):446-449. PubMed ID: 23884255
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effects of pelvic organ prolapse ring pessary therapy on intravaginal microbial flora.
    Yoshimura K; Morotomi N; Fukuda K; Hachisuga T; Taniguchi H
    Int Urogynecol J; 2016 Feb; 27(2):219-27. PubMed ID: 26377332
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Patterns of pessary care and outcomes for medicare beneficiaries with pelvic organ prolapse.
    Alperin M; Khan A; Dubina E; Tarnay C; Wu N; Pashos CL; Anger JT
    Female Pelvic Med Reconstr Surg; 2013; 19(3):142-7. PubMed ID: 23611931
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Attitudes toward pessary use among Thai women with pelvic organ prolapse.
    Mungpooklang T; Bunyavejchevin S
    J Obstet Gynaecol Res; 2017 Sep; 43(9):1449-1453. PubMed ID: 28833951
    [TBL] [Abstract][Full Text] [Related]  

  • 72. What is hiding behind the pessary?
    Martin C; Hong L; Siddighi S
    Int Urogynecol J; 2013 May; 24(5):873-5. PubMed ID: 22790489
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Is it safe and effective to maintain the vaginal pessary without removing it for 2 consecutive years?
    Miceli A; Fernández-Sánchez M; Polo-Padillo J; Dueñas-Díez JL
    Int Urogynecol J; 2020 Dec; 31(12):2521-2528. PubMed ID: 32062679
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effect of vaginal pessaries on symptoms associated with pelvic organ prolapse.
    Fernando RJ; Thakar R; Sultan AH; Shah SM; Jones PW
    Obstet Gynecol; 2006 Jul; 108(1):93-9. PubMed ID: 16816061
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Host inflammatory response in women with vaginal epithelial abnormalities after pessary use.
    Ramaseshan AS; Mellen C; O'Sullivan DM; Nold C; Tulikangas PK
    Int Urogynecol J; 2022 Aug; 33(8):2151-2157. PubMed ID: 34748034
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Outcomes of Pessary Use at 1 Year in Women Treated for Pelvic Organ Prolapse in a Large Multicenter Registry: Developed by the Pelvic Floor Disorders Registry.
    Yurteri-Kaplan LA; Meyn L; Moalli PA; Bradley CS; Foster RT; Andy UU; Guaderrama N; Gutman RE; Anger JT; Hull A; Propst K; Shippey SS; Brown HW
    Urogynecology (Phila); 2022 Dec; 28(12):800-810. PubMed ID: 36409637
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cross sectional study on assessment of ring pessary cleaning and removal every six months: adverse events and complications.
    de Albuquerque Coelho SC; Pereira GMV; Brito LGO; Juliato CRT
    Int Urogynecol J; 2022 Feb; 33(2):397-403. PubMed ID: 33830303
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Delayed vesicovaginal fistula after ring pessary usage.
    Penrose KJ; Ma Yin J; Tsokos N
    Int Urogynecol J; 2014 Feb; 25(2):291-3. PubMed ID: 23801483
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Characteristics of women with continued use of vaginal pessaries.
    Lewthwaite BJ; Staley D; Girouard L; Maslow K
    Urol Nurs; 2013; 33(4):171-6. PubMed ID: 24079114
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The use of vaginal antimicrobial after large loop excision of transformation zone: a prospective randomised trial.
    Chan KK; Tam KF; Tse KY; Ngan HY
    BJOG; 2007 Aug; 114(8):970-6. PubMed ID: 17635487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.